These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Essential functions of chaperones and adaptors of protein secretion systems in Gram-negative bacteria. Manera K; Kamal F; Burkinshaw B; Dong TG FEBS J; 2022 Aug; 289(16):4704-4717. PubMed ID: 34092034 [TBL] [Abstract][Full Text] [Related]
4. Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components. Hotinger JA; Pendergrass HA; May AE Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669653 [TBL] [Abstract][Full Text] [Related]
5. The Injectisome, a Complex Nanomachine for Protein Injection into Mammalian Cells. Lara-Tejero M; Galán JE EcoSal Plus; 2019 Mar; 8(2):. PubMed ID: 30942149 [TBL] [Abstract][Full Text] [Related]
6. Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli. Cameron EA; Curtis MM; Kumar A; Dunny GM; Sperandio V mBio; 2018 Dec; 9(6):. PubMed ID: 30514785 [TBL] [Abstract][Full Text] [Related]
7. Type III Secretion Effector VopQ of Vibrio parahaemolyticus Modulates Central Carbon Metabolism in Epithelial Cells. Nguyen AQ; Shimohata T; Hatayama S; Tentaku A; Kido J; Bui TMH; Uebanso T; Mawatari K; Takahashi A mSphere; 2020 Mar; 5(2):. PubMed ID: 32188755 [No Abstract] [Full Text] [Related]
8. Introduction to Type III Secretion Systems. Condry DL; Nilles ML Methods Mol Biol; 2017; 1531():1-10. PubMed ID: 27837477 [TBL] [Abstract][Full Text] [Related]
9. An elegant nano-injection machinery for sabotaging the host: Role of Type III secretion system in virulence of different human and animal pathogenic bacteria. Hajra D; Nair AV; Chakravortty D Phys Life Rev; 2021 Sep; 38():25-54. PubMed ID: 34090822 [TBL] [Abstract][Full Text] [Related]
10. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity. Sheahan KL; Isberg RR mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Family of Plaza N; Urrutia IM; Garcia K; Waldor MK; Blondel CJ mSphere; 2021 Aug; 6(4):e0059921. PubMed ID: 34346702 [TBL] [Abstract][Full Text] [Related]
12. The Bordetella Secreted Regulator BspR Is Translocated into the Nucleus of Host Cells via Its N-Terminal Moiety: Evaluation of Bacterial Effector Translocation by the Escherichia coli Type III Secretion System. Abe A; Nishimura R; Tanaka N; Kurushima J; Kuwae A PLoS One; 2015; 10(8):e0135140. PubMed ID: 26247360 [TBL] [Abstract][Full Text] [Related]
13. Type III Secretion in the Melioidosis Pathogen Vander Broek CW; Stevens JM Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152 [No Abstract] [Full Text] [Related]
14. Enterococcus faecalis Enhances Expression and Activity of the Enterohemorrhagic Escherichia coli Type III Secretion System. Cameron EA; Sperandio V; Dunny GM mBio; 2019 Nov; 10(6):. PubMed ID: 31744919 [TBL] [Abstract][Full Text] [Related]
15. A global survey of bacterial type III secretion systems and their effectors. Hu Y; Huang H; Cheng X; Shu X; White AP; Stavrinides J; Köster W; Zhu G; Zhao Z; Wang Y Environ Microbiol; 2017 Oct; 19(10):3879-3895. PubMed ID: 28401683 [TBL] [Abstract][Full Text] [Related]
16. BopN is a Gatekeeper of the Navarrete KM; Bumba L; Prudnikova T; Malcova I; Allsop TR; Sebo P; Kamanova J Microbiol Spectr; 2023 Jun; 11(3):e0411222. PubMed ID: 37036369 [TBL] [Abstract][Full Text] [Related]
17. Transmembrane substrates of type three secretion system injectisomes. Godlee C; Holden DW Microbiology (Reading); 2023 Jan; 169(1):. PubMed ID: 36748571 [TBL] [Abstract][Full Text] [Related]
18. Diversity and Evolution of Type III Secreted Effectors: A Case Study of Three Families. Bastedo DP; Lo T; Laflamme B; Desveaux D; Guttman DS Curr Top Microbiol Immunol; 2020; 427():201-230. PubMed ID: 31240408 [TBL] [Abstract][Full Text] [Related]
19. Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems. Blasey N; Rehrmann D; Riebisch AK; Mühlen S Front Cell Infect Microbiol; 2022; 12():1065561. PubMed ID: 36704108 [TBL] [Abstract][Full Text] [Related]
20. A bacterial secreted translocator hijacks riboregulators to control type III secretion in response to host cell contact. Kusmierek M; Hoßmann J; Witte R; Opitz W; Vollmer I; Volk M; Heroven AK; Wolf-Watz H; Dersch P PLoS Pathog; 2019 Jun; 15(6):e1007813. PubMed ID: 31173606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]